In more detail what the microsatellite instability (MSI) and mismatch repair (MMR) status of my tumor means for my...

Understanding MSI and Mismatch Repair Status in Colorectal Cancer

I'm glad you're asking about this—understanding your tumor's MSI and MMR status is really important for planning your treatment, especially for colorectal cancer.

What MSI and MMR Actually Mean

Think of your DNA like a long document being typed. Normally, when mistakes happen during DNA copying, your body has a "spell-checker" system called mismatch repair (MMR) proteins that find and fix these errors automatically.

Microsatellite instability (MSI) occurs when this spell-checker system isn't working properly. Microsatellites are short, repeated DNA sequences throughout your genome. When the MMR system fails, errors accumulate in these areas, leaving a detectable pattern that doctors can identify through testing.

According to the NCCN Guidelines, when cancer cells have more than a normal number of these errors, it's called MSI-H (microsatellite instability-high) or dMMR (deficient mismatch repair). These terms are used interchangeably because they're measuring the same problem from different angles—one looks at the errors themselves, the other at the broken repair mechanism.

Why This Matters for Your Treatment

Here's where it gets exciting: MSI-H/dMMR status significantly changes your treatment options, particularly for immunotherapy.

The Immunotherapy Connection

According to the NCCN Guidelines for colorectal cancer, when you have MSI-H or dMMR status, your tumor has accumulated many mutations. This is actually beneficial because:

• Your immune system can recognize these mutations as "foreign" signals that something is wrong
• These tumors are sometimes called "hot tumors" because they actively engage your immune system
• This makes your cancer cells more vulnerable to checkpoint inhibitor immunotherapies like pembrolizumab (Keytruda)

The webinar on immunotherapy biomarkers explains it this way: when you have MSI-high status, "you have a larger number of mutations not only in your tumor, but everywhere in your body. You have all of these mutations that exist, which means you have a broader immune response as well."

FDA-Approved Treatment Options

According to FDA approvals and NCCN Guidelines, if your colorectal cancer is MSI-H/dMMR:

• Pembrolizumab (Keytruda) is FDA-approved as a treatment option
• This was groundbreaking because it was the first tissue-agnostic biomarker approval—meaning the FDA approved treatment based on the tumor's genetics rather than where it started in your body
• Other checkpoint inhibitors may also be options depending on your specific situation

Testing Recommendations

According to the NCCN Guidelines, MSI/MMR testing is recommended for:

• All patients with colorectal cancer (especially important for metastatic disease)
• Helps determine if you're a candidate for immunotherapy
• May also indicate whether genetic counseling is appropriate, since MSI can be associated with hereditary cancer syndromes like Lynch syndrome

Important Next Steps

1. Confirm your test results with your oncology team—make sure you know whether your tumor is MSI-H or MSI-L (low)
2. Discuss immunotherapy options if you have MSI-H status
3. Ask about genetic counseling if your tumor shows MSI-H, as this can have implications for your family
4. Understand your complete treatment plan, which may combine immunotherapy with other approaches depending on your cancer stage

Key Takeaway

If your colorectal cancer is MSI-H/dMMR positive, you have access to immunotherapy options that can be highly effective. This is one of the most important discoveries in recent cancer treatment because it offers a different approach than traditional chemotherapy—your own immune system does the fighting.

Please discuss these results thoroughly with your oncology team to understand exactly what they mean for your specific situation and which treatment options make the most sense for you.

Do you know your MSI status, or are you waiting for test results?